Abstract
Cardiopulmonary bypass (CPB), using hypothermia with crystalloid hemodilution, is associated with a capillary leak, which results in an increase in tissue water content, manifested as an increase in total body water after cardiac operation.1 Also, CPB induces activation of inflammatory cascades, resulting in activation of neutrophils, platelets, and endothelium,2,3 which release rumor necrosis factor alpha (TNF-α), interleukins (ILs), and other inflammatory mediators.4 Pulmonary injury, induced by an increase in tissue water and activation of the inflammatory reaction, is one of the complications of CPB with a high incidence. This may adversely affect cardiopulmonary interactions after surgery, delaying extubation and discharge from the intensive care unit (ICU).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552-559.
Mazer CD, Hornstein A, Freedman J. Platelet activation in warm and cold heart surgery. Ann Thorac Surg. 1995;59:1481-1486.
Elliott MJ, Finn AHR. Interaction between neutrophils and endothelium. Ann Thorac Surg. 1993;56:1503-1508.
Kalfin RE, Engelman RM, Rousou JA, et al. Induction of interleukin-8 expression during cardiopulmonary bypass. Circulation. 1993;88:401-406.
Elliott MJ. Minimizing the bypass circuit: a rational step in the development of paediatric perfusion. Perfusion. 1993;8:81-86.
Magilligan DJ. Indication of ultrafiltration in the cardiac surgical patient. J Thorac Cardiovasc Surg. 1985;89:183-189.
Naik SK, Knight A, Elliott MJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion. 1991;6:41-50.
Naik SK, Knight A, Elliott M. A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation. 1991;84(5 suppl):III422-III431.
Wang W, Huang HM, Zhu DM, et al. Modified ultrafiltration in pediatric cardiopulmonary bypass. Perfusion. 1998;13:304-311.
Schlunzen L, Pedersen J, Hjortholm K, et al. Modified ultrafiltration in pediatric cardiac surgery. Perfusion. 1998; 13:105-109.
Kameyama T, Ando F, Okamoto F, et al. The effect of modified ultrafiltration in pediatric open-heart surgery. Ann Thorac Cardiovasc Surg. 2000;6:19-26.
Li CM, Alfieres GM, Walker MJ, et al. Modified venovenous ultrafiltration in infant cardiac surgery [abstract]. J Am Coll Cardiol. 1995;25:200A.
Braun SR, Birnbaum ML, Chopra PS. Pre- and postoperative pulmonary function abnormalities in coronary artery revascularization surgery. Chest. 1978;73:316-320.
Schenkman Z, Shir Y, Weiss YG, et al. The effects of cardiac surgery on early and late pulmonary functions. Acta Anaesthesiol Scand. 2000;44:75-81.
Deal C, Osborn J, Miller CJ, et al. Pulmonary compliance in congenital heart disease and its relation to cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1968;55:320-327.
Karlson K, Saklad M, Paliotta J, et al. Computerized on-line analysis of pulmonary mechanics in patients undergoing cardiopulmonary bypass. Bull Soc Int Chir. 1975;2:121-124.
Staton GW, Williams WH, Mahoney EM, et al. Pulmonary outcomes of off-pump vs on-pump coronary artery bypass surgery in a randomized trial. Chest. 2005;127:892-901.
Babik B, Aszalos T, Petak F, et al. Changes in respiratory mechanics during cardiac surgery. Anesth Analg. 2003; 96:1280-1287.
Kyosola K, Takkunen O, Maamies T, et al. Bronchospasm during cardiopulmonary bypass: a potential fatal complication of open-heart surgery. J Thorac Cardiovasc Surg. 1987;35:375-377.
Tuman KJ, Ivankovich AD. Bronchospasm during cardiopulmonary bypass. Etiology and management. Chest. 1986;90:635-637.
Chenoweth DE. The properties of human C5a anaphylatoxin. The significance of C5a formation during hemodialysis. Contrib Nephrol. 1987;59:51-71.
Lees MH, Way RC, Ross BB. Ventilation and respiratory gas transfer of infants with increased pulmonary blood flow. Pediatrics. 1967;40:259.
Downes JJ, Nicodemus HF, Pierce WS, et al. Acute respiratory failure in infants following cardiovascular surgery. J Thorac Cardiovasc Surg. 1970;59:21.
Yates QP, Lindahl SGE, Hatch DJ. Pulmonary ventilation and gas exchange before and after correction of congenital cardiac malformations. Br J Anaesth. 1987;59:170.
DiCarlo JV, Steven JM. Respiratory failure in congenital heart disease. Pediatr Clin North Am. 1994;41:525-542.
Tonz M, Tomislav M, Von Segesser LK, et al. Acute lung injury during cardiopulmonary bypass. Chest. 1995;108:1551-1557.
DiCarlo JV, Raphaely RC, Steven JM, et al. Pulmonary mechanics in infants after cardiac surgery. Crit Care Med. 1992;20:22.
Miller BE, Levy JH. The inflammatory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:355-366.
Kirklin JK, Westaby S, Blackstone EH, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845.
Pang LM, Stalcup SA, Lipset JS, et al. Increased circulating bradykinin during hypothermia and cardiopulmonary bypass in children. Circulation. 1979;60:1503-1507.
Millar AB, Armstrong L, van der Linden J, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg. 1993;56:1499-1502.
Faymonville ME, Deby DG, Larbuisson R, et al. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in human. J Thorac Cardiovasc Surg. 1986;91:858-866.
Giomarelli P, Scolletta S, Borrelli E, et al. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin(IL)-10. Ann Thorac Surg. 2003;76:117-123.
Hopkins RA, Bull C, Haworth SG, et al. Pulmonary hypertension crises during cardiac surgery for congenital heart defects in young children. Eur J Cardiothorac Surg. 1991;5:628-634.
Bando K, Turrentive MW, Sharp TG, et al. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg. 1996;112:1600-1609.
Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
Cooper CJ, Landsberg MJ, Anderson TJ, et al. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans. Circulation. 1996;93:266-271.
Kirshbom PM, Jacobs MT, Tsui SS, et al. Effects of cardiopulmonary bypass and circulatory arrest on endothelium dependent vasodilation in the lung. J Thorac Cardiovasc Surg. 1996;111:1248-1256.
Wessel DL, Adatia I, Giglia TM, et al. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 1993;88:2128-2138.
Bando K, Vijayaraghavan P, Turrentine MW, et al. Dynamic changes of endothelin-1, nitric oxide and cyclic GMP in patients with congenital heart disease. Circulation. 1997;96(suppl):II346-II351.
Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
Komai H, Adatia IT, Elliot MJ, et al. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg. 1993;106:473-478.
Graham T. Osmotic force. Philos Trans R Soc Lond A. 1854;144:177-228.
Peetom F, Gerald PS. A simple and inexpensive method for the concentration of protein solutions by means of ultrafiltration. Clin Chim Acta. 1964;10:375-376.
Magilligan DJ, Oyama C. Ultrafiltration during cardiopulmonary bypass: laboratory evaluation and initial clinical experience. Ann Thorac Surg. 1984;37:33-39.
Osipo VP, Lurie MY, Mikhailov Y, et al. Hemoconcentration during open heart operation. Thorac Cardiovasc Surg. 1985;33:81-85.
Ronco C, Clark W. Hollow-fiber dialyzers: technical and clinical considerations. In: Nissenson A, Fine R, eds. Clinical Dialysis. New York: McGraw-Hill; 2005:47-83.
Wheeldon D, Bethune D. Haemofiltration during cardiopulmonary bypass. Perfusion. 1990;5(suppl):39-51.
Ronco C, Ballestri M, Cappelli G. Dialysis membranes in convective treatments [see comment]. Nephrol Dial Transplant. 2000;15(suppl 2):31-36.
Craddick PR, Fehr J, Brigham KL. Complement and leucocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977;296:769-774.
Bohler J, Kramer P, Gotze O. Leucocyte counts and complement activation during pump-driven and arteriovenous hemofiltration. In: Krama P, ed. Arteriovenous Hemofiltration. Gottingen: Vandenhoek & Ruprecht; 1982:187-192.
Journois D, Israel-Biet D, Pouard P, et al. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology. 1996;85:965-976.
Watanabe T, Sakai Y, Mayumi T, et al. Effect of ultrafiltration during cardiopulmonary bypass for pediatric cardiac surgery. Artif Organs. 1998;22:1052-1055.
Darup J, Bleese N, Kalmar P, et al. Hemofiltration during extracorporeal circulation. Thorac Cardiovasc Surg. 1979;27:227.
Tamari Y, Nelson R, Levy R, et al. Effects of the hemo-concentrator on blood. J Extra Corpor Technol. 1984;16:89-94.
Ramagnoli A, Hocker J, Keats A, et al. External hemoconcentration after deliberate hemodilution. In Abstracts of the Annual Meeting of the American Society of Anesthesiologists. Park Ridge, IL: American Society of Anesthesiologists; 1975;6:269.
Walpoth B, von Albertini B. Ultrafiltration in cardiac surgery. J Extra Corpor Technol. 1984;16:68-70.
Gaynor JW, Kuypers M, van Rossem M, et al. Haemodynamic changes during modified ultrafiltration immediately following the first stage of the Norwood reconstruction. Cardiol Young. 2005;15:4-7.
Sever K, Tansel T, Basaran M, et al. The benefits of continuous ultrafiltration in pediatric cardiac surgery. Scand Cardiovasc J. 2004;38:307-311.
Koutlas TC, Gaynor JW, Nicholson SC, et al. Modified ultrafiltration reduces postoperative morbidity after cavopulmonary connection. Ann Thorac Surg. 1997;64:37-42.
Draaisma AM, Hazekamp MG, Frank M, et al. Modified ultrafiltration after cardiopulmonary bypass in pediatric cardiac surgery. Ann Thorac Cardiovasc Surg. 1997;64:521-525.
Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operation. Ann Thorac Surg. 1993;56:1518-1522.
Bando K, Turrentine MW, Vijay P, et al. Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease. Ann Thorac Surg. 1998;66:821-827.
Davies MJ, Nguyen K, Gaynor JW, et al. Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1998;115:361-369.
Groom RC, Akl BF, Albus RA, et al. Alternative method of ultrafiltration after cardiopulmonary bypass. Ann Thorac Surg. 1994;58:573-574.
Aeba R, Katogi T, Omoto T, et al. Modified ultrafiltration improves carbon dioxide removal after cardiopulmonary bypass in infants. Artif Organs. 1999;24:300-304.
Bando K, Vijay P, Turrebtine MW, et al. Dilutional and modified ultrafiltration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study. J Thorac Cardiovasc Surg. 1998;115:517-527.
Mahmoud AS, Burhani MS, Hannef AA, et al. Effect of modified ultrafiltration on pulmonary function after cardiopulmonary bypass. Chest. 2005;128:3447-3453.
Chaturvedi RR, Shore DF, White PA, et al. Modified ultrafiltration improves global left ventricular systolic function after open-heart surgery in infants and children. Eur J Cardiothorac Surg. 1999;15:742-746.
Chew MS, brix-Christensen V, Ravn HB, et al. Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study. Perfusion. 2002;17:327-333.
Anderson S, Gothberg S, Berggren H, et al. Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg. 1993;56:1515-1517.
Yndgaard S, Andersen LW, Andersen C, et al. The effect of modified ultrafiltration on the amount of circulating endotoxins in children undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14:399-401.
Myung RJ, Kirshborn PM, Petko M, et al. Modified ultrafiltration may not improve neurologic outcome following deep hypothermic circulatory arrest. Eur J Cardiothorac Surg. 2003;24:243-248.
Li J, Hoschtitzky A, Allen ML, et al. An analysis of oxygen consumption and oxygen delivery in euthermic infants after cardiopulmonary bypass with modified ultrafiltration. Ann Thorac Cardiovasc Surg. 2004;78:1389-1396.
Luciani GB, Menon T, Vecchi B, et al. Modified ultrafiltration reduces morbidity after adult cardiac operations: a prospective randomized clinical trial. Circulation. 2001;104(12 suppl 1):I253-I259.
Boga M, Islamoglu, Badak I, et al. The effects of modified hemofiltration on inflammatory mediators and cardiac performance in coronary artery bypass grafting. Perfusion. 2000;15:143-150.
Grnnenfelder J, Zund G, Schoeberlein A, et al. Modified ultrafiltration lowers adhesion molecule and cytokine level after cardiopulmonary bypass without clinical relevance in adults. Eur J Cardiothorac Surg. 2000;17:77-83.
Kiziltepe U, Uysalel A, Corapcioglu T, et al. Effects of combined conventional and modified ultrafiltration in adults patients. Ann Thorac Surg. 2001;71:684-693.
Chew MS. Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass? Perfusion. 2004;19(suppl 1):S57-S60.
Tassani P, Richter JA, Eising GP, et al. Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 1999;13:285-291.
Nagashima M, Shin’oka T, Nollert G, et al. High-volume continuous hemofiltration during cardiopulmonary bypass attenuates pulmonary dysfunction in neonates lambs after deep hypothermic circulatory arrest. Circulation. 1998; 98:II378-II384.
Schmaldienst S, Horl W. Biocompatibility. In: Nissenson A, Fine R, eds. Clinical Dialysis. 4th ed. New York: McGraw-Hill; 2005:101-125.
Berdat PA, Eichenberger E, Ebell J, et al. Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type. J Thorac Cardiovasc Surg. 2004;127:1688-1696.
Onoe M, Magara T, Yamamoto Y, et al. Modified ultrafiltration removes serum interleukin-8 in adult cardiac surgery. Perfusion. 2001;16:37-42.
Teraoka S, Mineshima M, Hoshino T, et al. Can cytokines be removed by hemofiltration or hemoadsorption? ASAIO. 2000;46:448-451.
Silverstein MEFE, Lysaght MJ, Henderson LW. Treatment of severe fluid overload by ultrafiltration. N Eng J Med. 1974;291:747-750.
Garup J, Bleese N, Kalmar P, et al. Hemofiltration during extracorporeal circulation. Thorac Cardiovasc Surg. 1979;27:227-230.
Onoe M, Oku H, Kitayama H. et al Modified ultrafiltration may improve postoperative pulmonary function in children with a ventricular septal defect [abstract]. Surg Today. 2001;31:586-590.
Meliones J, Gaynor JW, Wilson BG, et al. Modified ultrafiltration reduces airway pressures and improves lung compliance after congenital heart surgery [abstract]. J Am Coll Cardiol. 1995;25:271A.
Keenan HT, Thiagarajan R, Stephens KE, et al. Pulmonary function after modified venovenous ultrafiltration in infants: a prospective, randomized trial. J Thorac Cardiovasc Surg. 2000;119:501-507.
Huang HM, Yao TJ, Wang W, et al. Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg. 2003;76:136-140.
Cole L, Bellomo R, Davenport P, et al. The effect of coupled haemofiltration and adsorption on inflammatory cytokines in an ex vivo model. Nephrol Dial Transplant. 2002;17:1950-1956.
Hauser GJ, Ben-Ari J, Colvin MP, et al. Interleukin-6 levels in serum and lung lavage fluid of children undergoing open heart surgery correlate with postoperative morbidity. Intensive Card Med. 1998;24:481-486.
Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21:232-244.
Wang MJ, Chiu IS, Hsu CM, et al. efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg. 1996;61:651-656.
Hoffmann J, Faist E. Removal of mediators by continuous hemofiltration in septic patients. World J Surg. 2001;25:651-659.
Segahaye M, Duchateau J, Bruniaux J, et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg. 1996;111:545-553.
BaiTera P, Janssen EM, Demacker PN, et al. Removal of interleukin-1 beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes. Lymphokine Cytokine Res. 1992;11:99-104.
Fujita M, Ishihara M, Kusama Y, et al. Effect of modified ultrafiltration on inflammatory mediators, coagulation factors, and other proteins in blood after an extracorporeal circuit. Artif Organs. 2004;28:310-313.
Barrera P, Jansosen EM, Demacker PN, et al. Removal of interleukin-1 beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membrane. Lymphokine Cytokine Res. 1992;11:1212-1218.
Rubens FD, Mesana T. The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Perfusion. 2004;19(suppl 1):S5-S12.
Kolff W. First clinical experience with the artificial kidney. Ann Intern Med. 1965;62:608-619.
Wellel DL, Adatia I, Giglia TM, et al. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation. 1993;88:2128-2138.
Goto K, Hama H, Kasuya Y. Molecular pharmacology and pathophysiological significance of endothelin. Jpn J Pharmacol. 1996;72:261-90.
Hiramatsu T, Imai Y, Kurosawa H, et al. Effects of dilutional and modified ultrafiltration in plasma endothelin-1 and pulmonary vascular resistance after the Fontan Procedure. Ann Thorac Surg. 2002;73:862-865.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer London
About this chapter
Cite this chapter
Wang, W., Huang, H. (2010). Benefits of Ultrafiltration for Pulmonary Function. In: Gabriel, E., Salerno, T. (eds) Principles of Pulmonary Protection in Heart Surgery. Springer, London. https://doi.org/10.1007/978-1-84996-308-4_27
Download citation
DOI: https://doi.org/10.1007/978-1-84996-308-4_27
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84996-307-7
Online ISBN: 978-1-84996-308-4
eBook Packages: MedicineMedicine (R0)